Desidustat: First Approval-Reference-Cited by-同舟云学术

Desidustat: First Approval

Published:2022-07 Issue:11 Volume:82 Page:1207-1212
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Dhillon Sohita

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-022-01744-w.pdf

Reference15 articles.

1. Mima A. Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: advantages and disadvantages. Eur J Pharmacol. 2021;912:174583.

2. Weir MR. Managing anemia across the stages of kidney disease in those hyporesponsive to erythropoiesis-stimulating agents. Am J Nephrol. 2021;52(6):450–66.

3. Bonomini M, Del Vecchio L, Sirolli V, et al. New treatment approaches for the anemia of CKD. Am J Kidney Dis. 2016;67(1):133–42.

4. Sanghani NS, Haase VH. Hypoxia-inducible factor activators in renal anemia: current clinical experience. Adv Chronic Kidney Dis. 2019;26(4):253–66.

5. Zydus Cadila. Zydus to launch OxemiaTM (desidustat) a breakthrough treatment for anemia in patients suffering from chronic kidney disease (CKD) [media release]. 7 Mar 2022. https://www.zyduslife.com/public/pdf/pressrelease/Press_Release_Zydus_to_launch_Oxemia_a_breakthrough_treatment_for_Anemia_in_patients_suffering_from_CKD.pdf.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patent review on hypoxia-inducible factor (HIF) modulators (2021–2023);Expert Opinion on Therapeutic Patents;2024-06-19

2. Innovative Drug Discovery Research by Pharmaceutical Companies in India and China;Journal of Medicinal Chemistry;2024-06-10

3. HIF-Stabilisatoren: aktueller Stellenwert bei der Therapie der renalen Anämie;Nephrologie aktuell;2024-03

4. Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia;Clinical Kidney Journal;2024-02-28

5. Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia;Journal of Medicinal Chemistry;2024-01-08